Thomas Vandervort

Thomas Vandervort has held a number of positions in the pharmaceutical industry since 2010. Thomas began their career as Director of Business Development at West-Ward Pharmaceuticals in 2010. In 2012, they became Vice President of Sales at Centric Health Resources. After two years, they moved to IGI Laboratories, Inc. as Director of Business Development. In 2014, they held two positions simultaneously, Vice President of Business Development at Teligent, Inc. and Board Member at Orphic Therapeutics. In 2017, they became Director at Eyevance Pharmaceuticals. In 2020, they were appointed Director at Amber Ophthalmics. In 2021, they were appointed Director at Ellie Diagnostics. Finally, in 2022, they became Managing Partner at Avego Management.

Thomas Vandervort completed their MA in English from Duquesne University between 2000 and 2002. Thomas also obtained a BA in English from Bethany College between 1996 and 2000. Thomas'seducation history further includes Oldham County High School, Oldham County Middle School, and Regent's College.